Literature DB >> 15342275

Immunohistochemical characterisation and localisation of cannabinoid CB1 receptor protein in the rat vestibular nucleus complex and the effects of unilateral vestibular deafferentation.

John C Ashton1, Yiwen Zheng, Ping Liu, Cynthia L Darlington, Paul F Smith.   

Abstract

CB1 receptor expression has been reported to be low in the brainstem compared with the forebrain, and low in the vestibular nucleus complex (VNC) compared with other regions in the brainstem. However, a frequent effect of cannabis is dizziness and loss of balance. This may be due to the activation of cannabinoid receptors in the central vestibular pathways. We used immunohistochemistry to study the distribution of CB1 receptor protein in the VNC, and Western blotting to measure CB1 receptor expression in the VNC following unilateral vestibular deafferentation (UVD); the hippocampal CA1, CA2/3 and dentate gyrus (DG) regions were also analysed for comparison. This study confirms a previous electrophysiological demonstration that CB1 receptors exist in significant densities in the VNC and are likely to contribute to the neurochemical control of the vestibular reflexes. Nonetheless, CB1 receptor expression did not change significantly in the VNC during vestibular compensation. In addition, despite some small but significant changes in CB1 receptor expression in the CA2/3 and the DG following UVD, in no case were these differences statistically significant in comparison to both control groups.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15342275     DOI: 10.1016/j.brainres.2004.06.065

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  7 in total

1.  Cytosolic glucocorticoid receptor expression in the rat vestibular nucleus and hippocampus following unilateral vestibular deafferentation.

Authors:  Libby Lindsay; Ping Liu; Catherine Gliddon; Yiwen Zheng; Paul F Smith; Cynthia L Darlington
Journal:  Exp Brain Res       Date:  2004-12-03       Impact factor: 1.972

2.  New approaches in the management of spasticity in multiple sclerosis patients: role of cannabinoids.

Authors:  Paul F Smith
Journal:  Ther Clin Risk Manag       Date:  2010-03-03       Impact factor: 2.423

3.  Inhibition of 2-arachidonoylglycerol catabolism modulates vasoconstriction of rat middle cerebral artery by the thromboxane mimetic, U-46619.

Authors:  C J Hillard; W-Sv Ho; J Thompson; K M Gauthier; C E Wheelock; H Huang; B D Hammock
Journal:  Br J Pharmacol       Date:  2007-09-24       Impact factor: 8.739

4.  Presence of functional cannabinoid receptors in human endocrine pancreas.

Authors:  F J Bermúdez-Silva; J Suárez; E Baixeras; N Cobo; D Bautista; A L Cuesta-Muñoz; E Fuentes; P Juan-Pico; M J Castro; G Milman; R Mechoulam; A Nadal; F Rodríguez de Fonseca
Journal:  Diabetologia       Date:  2007-12-19       Impact factor: 10.122

5.  Localization of CB1 cannabinoid receptor mRNA in the brain of the chick (Gallus domesticus).

Authors:  Todd L Stincic; Richard L Hyson
Journal:  Brain Res       Date:  2008-09-20       Impact factor: 3.252

6.  Adverse events following cannabis for medical use in Tuscany: An analysis of the Italian Phytovigilance database.

Authors:  Giada Crescioli; Niccolò Lombardi; Alessandra Bettiol; Francesca Menniti-Ippolito; Roberto Da Cas; Maria Parrilli; Martina Del Lungo; Eugenia Gallo; Alessandro Mugelli; Valentina Maggini; Fabio Firenzuoli; Alfredo Vannacci
Journal:  Br J Clin Pharmacol       Date:  2020-01-03       Impact factor: 4.335

7.  The cannabinoid receptors system in horses: Tissue distribution and cellular identification in skin.

Authors:  Piotr Kupczyk; Marta Rykala; Pawel Serek; Aleksandra Pawlak; Bartosz Slowikowski; Marcin Holysz; Grzegorz Chodaczek; Jan P Madej; Piotr Ziolkowski; Artur Niedzwiedz
Journal:  J Vet Intern Med       Date:  2022-07-08       Impact factor: 3.175

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.